Fig. 4From: The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trialsForest plot of specific GLP-1 receptor agonists versus comparators on the risk of overall Respiratory diseasesBack to article page